E. Woo

发表

Comparing data mining methods on the VAERS database

D. Burwen, M. Braun, R. Ball, 2005, Pharmacoepidemiology and drug safety.

Guillain-Barré Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018-2019 Season.

S. Anderson, E. Woo, R. Forshee, 2020, The Journal of infectious diseases.

Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.

E. Woo, M. Cano, P. Moro, 2017, Vaccine.

Letter to the Editor: Editorial: When “Safe and Effective” Becomes Dangerous

Emily Jane Woo, E. Woo, 2014, Clinical orthopaedics and related research.

Motor palsies of cranial nerves (excluding VII) after vaccination

E. Woo, A. Ou, S. Winiecki, 2014, Human vaccines & immunotherapeutics.

CORR Insights®: Disparities in TKA Outcomes: Census Tract Data Show Interactions Between Race and Poverty

E. Woo, 2016, Clinical orthopaedics and related research.

The contribution of the vaccine adverse event text mining system to the classification of possible Guillain-Barré syndrome reports.

T Botsis, T. Botsis, E. Woo, 2013, Applied clinical informatics.

Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine, Vaccine Adverse Event Reporting System (VAERS), 2010-2017.

E. Woo, T. Shimabukuro, M. Cano, 2019, Vaccine.

Potential safety signals and their significance.

E. Woo, 2012, Archives of internal medicine.

Using Probabilistic Record Linkage of Structured and Unstructured Data to Identify Duplicate Cases in Spontaneous Adverse Event Reporting Systems

T. Botsis, E. Woo, R. Forshee, 2017, Drug Safety.

Does bone morphogenetic protein increase the incidence of perioperative complications in spinal fusion? A comparison of 55,862 cases of spinal fusion with and without bone morphogenetic protein.

E. Woo, 2012, Spine.

US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.

E. Woo, M. Streiff, S. Beavers, 2021, JAMA.

Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine adverse event reporting system

E. Woo, R. Dimova, 2022, Vaccine.

Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021.

E. Woo, M. Alimchandani, R. Dimova, 2021, JAMA.

Can Natural Language Processing Improve the Efficiency of Vaccine Adverse Event Report Review?

T Botsis, T. Botsis, E. Woo, 2015, Methods of Information in Medicine.

Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System.

D. Burwen, E. Woo, R. Ball, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Adverse events reported after the use of recombinant human bone morphogenetic protein 2.

E. Woo, 2012, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Post-Licensure Surveillance of Trivalent Live-Attenuated Influenza Vaccine in Children Aged 2-18 Years, Vaccine Adverse Event Reporting System, United States, July 2005-June 2012.

E. Woo, P. Haber, Paige W. Lewis, 2015, Journal of the Pediatric Infectious Diseases Society.

Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination—United States, December 2020 to August 2021

T. Ortel, E. Woo, E. Walter, 2022, Annals of Internal Medicine.

SAFETY OF A FIFTH DOSE OF DIPHTHERIA AND TETANUS TOXOID AND ACELLULAR PERTUSSIS VACCINE IN CHILDREN EXPERIENCING EXTENSIVE, LOCAL REACTIONS TO THE FOURTH DOSE

M. Rennels, K. Edwards, E. Woo, 2008, The Pediatric infectious disease journal.

Interaction of potential risk factors for cancer.

E. Woo, 2014, The spine journal : official journal of the North American Spine Society.

Differential Regulation of Insulin-like Growth Factor-I (IGF-I) Receptor Gene Expression by IGF-I and Basic Fibroblastic Growth Factor*

H. Werner, E. Woo, C. Roberts, 1997, The Journal of Biological Chemistry.

Clinically significant pedicle screw malposition is an underestimated cause of radiculopathy.

E. Woo, M. DiCuccio, 2017, The spine journal : official journal of the North American Spine Society.

Thromboembolic events after Ad.26.COV2.S COVID‐19 vaccine: Reports to the Vaccine Adverse Event Reporting System

E. Woo, Yeowon Kim, B. Day, 2022, Pharmacoepidemiology and drug safety.

Expedited review of new drugs.

E. Woo, 2013, JAMA.

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021

E. Woo, K. Ess, M. Wharton, 2021, MMWR. Morbidity and mortality weekly report.

Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.

D. Burwen, M. Braun, R. Ball, 2009, Vaccine.

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022

E. Woo, P. Blanc, T. Shimabukuro, 2022, MMWR. Morbidity and mortality weekly report.

Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.

E. Woo, W. Orenstein, T. Shimabukuro, 2015, The Lancet. Infectious diseases.

Adverse Events After Recombinant Human BMP2 in Nonspinal Orthopaedic Procedures

E. Woo, 2013, Clinical orthopaedics and related research.

Kawasaki Disease After Vaccination: Reports to the Vaccine Adverse Event Reporting System 1990–2007

M. Braun, R. Ball, E. Woo, 2009, The Pediatric infectious disease journal.

Adverse events after hepatitis A B combination vaccine.

E. Woo, R. Ball, Nancy B Miller, 2006, Vaccine.

Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015

E. Woo, Paige W. Lewis, M. Cano, 2016, PLoS neglected tropical diseases.

Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine.

Robert Ball, Emily Jane Woo, John Iskander, 2009, JAMA.

Letter to the Editor: On Patient Safety: Do You Say “I’m Sorry” to Patients?

E. Woo, 2017, Clinical orthopaedics and related research.

Dural repairs with spinal sealants.

E. Woo, 2012, The spine journal : official journal of the North American Spine Society.

Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005.

M. Braun, R. Ball, E. Woo, 2007, Vaccine.

Pearls: Simpson's Paradox-Understanding Numbers That Don't Seem to Make Sense.

E. Woo, 2019, Clinical orthopaedics and related research.

Safety of Second-Dose Single-Antigen Varicella Vaccine

E. Woo, P. Haber, T. Shimabukuro, 2017, Pediatrics.

Allergic reactions after egg-free recombinant influenza vaccine: reports to the US Vaccine Adverse Event Reporting System.

E. Woo, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Adverse Events After MMR or MMRV Vaccine in Infants Under Nine Months Old

E. Woo, Deepa Arya, S. Winiecki, 2016, The Pediatric infectious disease journal.

Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006–2015

E. Woo, T. Shimabukuro, John R Su, 2018, Human vaccines & immunotherapeutics.

Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011 - 2019.

E. Woo, M. Cano, P. Moro, 2020, Vaccine.

Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States

E. Woo, T. Shimabukuro, W. Abara, 2023, JAMA network open.

Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013.

Emily Jane Woo, Michael M McNeil, Paige Lewis, 2014, Vaccine.

Post-Licensure Surveillance of Trivalent Live-Attenuated Influenza Vaccine in Children Aged 2-18 Years, Vaccine Adverse Event Reporting System, United States, July 2005-June 2012.

E. Woo, P. Haber, Paige W. Lewis, 2015, Journal of the Pediatric Infectious Diseases Society.

Adverse Events After Inactivated Influenza Vaccination Among Children Less Than 2 Years of Age: Analysis of Reports From the Vaccine Adverse Event Reporting System, 1990–2003

M. Braun, R. Ball, E. Woo, 2005, Pediatrics.

Case Series of Thrombosis with Thrombocytopenia Syndrome following COVID-19 vaccination--United States, December 2020-August 2021

T. Ortel, E. Woo, E. Walter, 2021, medRxiv.

Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013−May 31, 2015

E. Woo, P. Haber, Paige W. Lewis, 2016, Vaccine.

Recombinant human bone morphogenetic protein-2: adverse events reported to the Manufacturer and User Facility Device Experience database.

E. Woo, 2012, The spine journal : official journal of the North American Spine Society.

Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022

E. Woo, M. McNeil, J. Baggs, 2023, Vaccine.

Presumptive Guillain-Barré Syndrome Associated With Receipt of the Ad26.COV2.2.S COVID-19 Vaccine-Reply.

E. Woo, R. Dimova, A. Mba-Jonas, 2022, Journal of the American Medical Association (JAMA).

Vaccine risk perception among reporters of autism after vaccination: vaccine adverse event reporting system 1990-2001.

A. Bostrom, M. Braun, R. Ball, 2004, American journal of public health.

Developmental regression and autism reported to the Vaccine Adverse Event Reporting System

R. Landa, M. Braun, R. Ball, 2007, Autism : the international journal of research and practice.

Decision support environment for medical product safety surveillance

Wei Wang, Abhishek Pandey, Taxiarchis Botsis, 2016, J. Biomed. Informatics.

Logistic Regression Likelihood Ratio Test Analysis for Detecting Signals of Adverse Events in Post-market Safety Surveillance

Emily Jane Woo, Estelle Russek-Cohen, Nicholas C. Henderson, 2017, Journal of biopharmaceutical statistics.

CORR Insights®: Perioperative Inpatient Use of Selective Serotonin Reuptake Inhibitors Is Associated With a Reduced Risk of THA and TKA Revision.

E. Woo, 2018, Clinical orthopaedics and related research.

Vaccine Safety Surveillance

M. Braun, E. Woo, J. Labadie, 2014 .

Effects of Stratification on Data Mining in the US Vaccine Adverse Event Reporting System (VAERS)

Robert Ball, Emily Jane Woo, D. Burwen, 2008, Drug safety.

U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007.

E. Woo, P. O'Connor, B. Slade, 2013, Vaccine.

Expanded indication for recombinant human bone morphogenetic protein 2.

E. Woo, 2011, Spine.

Text mining for the Vaccine Adverse Event Reporting System: medical text classification using informative feature selection

Marianthi Markatou, Robert Ball, Taxiarchis Botsis, 2011, J. Am. Medical Informatics Assoc..

Re: Wang Z, Kim JH, Higashino K, et al. Cartilage intermediate layer protein (CILP) regulation in intervertebral discs. The effect of age, degeneration, and bone morphogenetic protein-2. Spine (Phila Pa 1976) 2012;37:E203–8.

E. Woo, 2012, Spine.

Robert Ball, Taxiarchis Botsis, John Scott, 2015, IEEE Journal of Biomedical and Health Informatics.

Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system.

E. Woo, P. Moro, 2021, Vaccine.

Application of Information Retrieval Approaches to Case Classification in the Vaccine Adverse Event Reporting System

Taxiarchis Botsis, Emily Jane Woo, Robert Ball, 2013, Drug Safety.

Fatal syncope-related fall after immunization.

M. Braun, R. Ball, E. Woo, 2005, Archives of pediatrics & adolescent medicine.

Evaluating patient, procedure, and provider characteristics as risk factors for postoperative complications.

E. Woo, 2014, The spine journal.

Postmarketing safety surveillance of high-dose quadrivalent influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.

E. Woo, P. Moro, 2022, Vaccine.

Vaccine adverse event text mining system for extracting features from vaccine safety reports

Robert Ball, Taxiarchis Botsis, Emily Jane Woo, 2012, J. Am. Medical Informatics Assoc..

Thrombocytopenia after vaccination: case reports to the US Vaccine Adverse Event Reporting System, 1990-2008.

R. Ball, E. Woo, S. Shadomy, 2011, Vaccine.

A new algorithmic approach for the extraction of temporal associations from clinical narratives with an application to medical product safety surveillance reports

Wei Wang, Robert Ball, Abhishek Pandey, 2016, J. Biomed. Informatics.

Vaccine adverse event text mining system for extracting features from vaccine safety reports

T. Botsis, E. Woo, R. Ball, 2012, J. Am. Medical Informatics Assoc..

Safety of Second-Dose Single-Antigen Varicella Vaccine

E. Woo, P. Haber, T. Shimabukuro, 2017, Pediatrics.

Postmarketing safety of biologics and biological devices.

E. Woo, 2014, The spine journal : official journal of the North American Spine Society.

Reporting System, 1990-2003 Than 2 Years of Age: Analysis of Reports From the Vaccine Adverse Event Adverse Events After Inactivated Influenza Vaccination Among Children Less

R. Ball, E. Woo, J. Iskander, 2007 .

Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022

E. Woo, M. McNeil, J. Baggs, 2023, Vaccine.